1-9 of 9
Raffaella Giavazzi
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Editor's Note: Antiangiogenic Properties of 17-(Dimethylaminoethylamino)-17-Demethoxygeldanamycin: An Orally Bioavailable Heat Shock Protein 90 Modulator

Gurmeet Kaur, Dorina Belotti, Angelika M. Burger, Kirsten Fisher-Nielson, Patrizia Borsotti, Elena Riccardi, Jagada Thillainathan, Melinda Hollingshead, Edward A. Sausville, Raffaella Giavazzi
Journal: Clinical Cancer Research
Clin Cancer Res (2024) 30 (9): 1996.
https://doi.org/10.1158/1078-0432.CCR-24-0857
Published: 01 May 2024
View articletitled, Editor's Note: Antiangiogenic Properties of 17-(Dimethylaminoethylamino)-17-Demethoxygeldanamycin: An Orally Bioavailable Heat Shock Protein 90 Modulator
Open the PDF for Editor's Note: Antiangiogenic Properties of 17-(Dimethylaminoethylamino)-17-Demethoxygeldanamycin: An Orally Bioavailable Heat Shock Protein 90 Modulator in another window
Journal Articles

Abstract A04: DNA double-strand break repair assay in primary cultures of patient-derived ovarian carcinoma xenografts.

Federica Guffanti, Julia Kaufmann, Francesca Bizzaro, Francesca Ricci, Monica Ganzinelli, Monica Lupi, Raffaella Giavazzi, Lisa Wiesmüller, Giovanna Damia
Journal: Clinical Cancer Research
Clin Cancer Res (2016) 22 (2_Supplement): A04.
https://doi.org/10.1158/1557-3265.OVCA15-A04
Published: 15 January 2016
View articletitled, Abstract A04: DNA double-strand break repair assay in primary cultures of patient-derived ovarian carcinoma xenografts.
Journal Articles

The Vascular Targeting Property of Paclitaxel Is Enhanced by SU6668, a Receptor Tyrosine Kinase Inhibitor, Causing Apoptosis of Endothelial Cells and Inhibition of Angiogenesis

Elitza Naumova, Paolo Ubezio, Angela Garofalo, Patrizia Borsotti, Linda Cassis, Elena Riccardi, Eugenio Scanziani, Suzanne A. Eccles, Maria R. Bani, Raffaella Giavazzi
Journal: Clinical Cancer Research
Clin Cancer Res (2006) 12 (6): 1839–1849.
https://doi.org/10.1158/1078-0432.CCR-05-1615
Published: 21 March 2006
View articletitled, The Vascular Targeting Property of Paclitaxel Is Enhanced by SU6668, a Receptor Tyrosine Kinase Inhibitor, Causing Apoptosis of Endothelial Cells and Inhibition of Angiogenesis
Open the PDF for The Vascular Targeting Property of Paclitaxel Is Enhanced by SU6668, a Receptor Tyrosine Kinase Inhibitor, Causing Apoptosis of Endothelial Cells and Inhibition of Angiogenesis in another window
Journal Articles

Potential Antagonism of Tubulin-Binding Anticancer Agents in Combination Therapies

Giulia Taraboletti, Gianluca Micheletti, Romina Dossi, Patrizia Borsotti, Michele Martinelli, Fabio Fiordaliso, Anderson J. Ryan, Raffaella Giavazzi
Journal: Clinical Cancer Research
Clin Cancer Res (2005) 11 (7): 2720–2726.
https://doi.org/10.1158/1078-0432.CCR-04-1616
Published: 06 April 2005
View articletitled, Potential Antagonism of Tubulin-Binding Anticancer Agents in Combination Therapies
Open the PDF for Potential Antagonism of Tubulin-Binding Anticancer Agents in Combination Therapies in another window
Journal Articles

Antiangiogenic Properties of 17-(Dimethylaminoethylamino)-17-Demethoxygeldanamycin: An Orally Bioavailable Heat Shock Protein 90 Modulator

Gurmeet Kaur, Dorina Belotti, Angelika M. Burger, Kirsten Fisher-Nielson, Patrizia Borsotti, Elena Riccardi, Jagada Thillainathan, Melinda Hollingshead, Edward A. Sausville, Raffaella Giavazzi
Journal: Clinical Cancer Research
Clin Cancer Res (2004) 10 (14): 4813–4821.
https://doi.org/10.1158/1078-0432.CCR-03-0795
Published: 21 July 2004
View articletitled, Antiangiogenic Properties of 17-(Dimethylaminoethylamino)-17-Demethoxygeldanamycin: An Orally Bioavailable Heat Shock Protein 90 Modulator
Open the PDF for Antiangiogenic Properties of 17-(Dimethylaminoethylamino)-17-Demethoxygeldanamycin: An Orally Bioavailable Heat Shock Protein 90 Modulator in another window
Journal Articles

The Combination of the Tyrosine Kinase Receptor Inhibitor SU6668 with Paclitaxel Affects Ascites Formation and Tumor Spread in Ovarian Carcinoma Xenografts Growing Orthotopically

Angela Garofalo, Elitza Naumova, Luigi Manenti, Carmen Ghilardi, Gabriele Ghisleni, Mario Caniatti, Tina Colombo, Julie M. Cherrington, Eugenio Scanziani, Maria Ines Nicoletti, Raffaella Giavazzi
Journal: Clinical Cancer Research
Clin Cancer Res (2003) 9 (9): 3476–3485.
Published: 05 September 2003
View articletitled, The Combination of the Tyrosine Kinase Receptor Inhibitor SU6668 with Paclitaxel Affects Ascites Formation and Tumor Spread in Ovarian Carcinoma Xenografts Growing Orthotopically
Open the PDF for The Combination of the Tyrosine Kinase Receptor Inhibitor SU6668 with Paclitaxel Affects Ascites Formation and Tumor Spread in Ovarian Carcinoma Xenografts Growing Orthotopically in another window
Journal Articles

Antiangiogenic and Antitumor Activity of IDN 5390, a New Taxane Derivative

Giulia Taraboletti, Gianluca Micheletti, Monica Rieppi, Maura Poli, Michele Turatto, Cosmo Rossi, Patrizia Borsotti, Paola Roccabianca, Eugenio Scanziani, Maria Ines Nicoletti, Ezio Bombardelli, Paolo Morazzoni, Antonella Riva, Raffaella Giavazzi
Journal: Clinical Cancer Research
Clin Cancer Res (2002) 8 (4): 1182–1188.
Published: 01 April 2002
View articletitled, Antiangiogenic and Antitumor Activity of IDN 5390, a New Taxane Derivative
Open the PDF for Antiangiogenic and Antitumor Activity of IDN 5390, a New Taxane Derivative in another window
Journal Articles

Expression of β-Tubulin Isotypes in Human Ovarian Carcinoma Xenografts and in a Sub-Panel of Human Cancer Cell Lines from the NCI-Anticancer Drug Screen: Correlation with Sensitivity to Microtubule Active Agents

Maria Ines Nicoletti, Giorgio Valoti, Paraskevi Giannakakou, Zhirong Zhan, Jon-Hyeok Kim, Valeria Lucchini, Fabio Landoni, Joseph G. Mayo, Raffaella Giavazzi, Tito Fojo
Journal: Clinical Cancer Research
Clin Cancer Res (2001) 7 (9): 2912–2922.
Published: 01 September 2001
View articletitled, Expression of β-Tubulin Isotypes in Human Ovarian Carcinoma Xenografts and in a Sub-Panel of Human Cancer Cell Lines from the NCI-Anticancer Drug Screen: Correlation with Sensitivity to Microtubule Active Agents
Open the PDF for Expression of β-Tubulin Isotypes in Human Ovarian Carcinoma Xenografts and in a Sub-Panel of Human Cancer Cell Lines from the NCI-Anticancer Drug Screen: Correlation with Sensitivity to Microtubule Active Agents in another window
Journal Articles

BAY 12-9566, A Novel Inhibitor of Matrix Metalloproteinases with Antiangiogenic Activity

Carmen Gatto, Monica Rieppi, Patrizia Borsotti, Silvia Innocenti, Roberta Ceruti, Teresa Drudis, Eugenio Scanziani, Anna M. Casazza, Giulia Taraboletti, Raffaella Giavazzi
Journal: Clinical Cancer Research
Clin Cancer Res (1999) 5 (11): 3603–3607.
Published: 01 November 1999
View articletitled, BAY 12-9566, A Novel Inhibitor of Matrix Metalloproteinases with Antiangiogenic Activity
Open the PDF for BAY 12-9566, A Novel Inhibitor of Matrix Metalloproteinases with Antiangiogenic Activity in another window